THON, Vojtěch. Importance of screening of IgG anti-IgA antibodies in hypogammaglobulinemic subjects to prevent anaphylactoid reactions. Klinická imunológia a alergológia. 2010, vol. 20, No 3, p. 26-27. ISSN 1335-0013.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Importance of screening of IgG anti-IgA antibodies in hypogammaglobulinemic subjects to prevent anaphylactoid reactions
Name in Czech Význam vyšetření IgG anti-IgA protilátek k prevenci anafylaktoidní reakce u hypogamaglobulinémií
Authors THON, Vojtěch (203 Czech Republic, guarantor, belonging to the institution).
Edition Klinická imunológia a alergológia, 2010, 1335-0013.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30102 Immunology
Country of publisher Slovakia
Confidentiality degree is not subject to a state or trade secret
RIV identification code RIV/00216224:14110/10:00058965
Organization unit Faculty of Medicine
Keywords (in Czech) anti-IgA protilátky; anafylaktoidní reakce; hypogamaglobulinémie
Keywords in English anti-IgA antibodies; anaphylactoid reaction; hypogammaglobulinemia
Tags International impact, Reviewed
Changed by Changed by: Ing. Mgr. Věra Pospíšilíková, učo 9005. Changed: 21/4/2013 11:29.
Abstract
Anti-IgA antibodies can cause severe anaphylactoid reactions in the case of blood transfusion or substitution immunoglobulin therapy in patients with hypogammaglobulinemia. We found a significant amount of anti-IgA antibodies in 10 % of patients with the most common primary hypogammaglobulinemia (selective IgA deficiency and common variable immunodeficiencies) where the serum IgA level was lower than 0.05 g/L. Knowledge of the presence of antibodies against IgA is important in clinical practice in order to prevent an anaphylactic reaction during blood transfusion or during immunoglobulin substitution therapy.
Abstract (in Czech)
Vyšetření přítomnosti anti-IgA protilátlek je důležité pro prevenci anafylaktoidní reakce v případě podání krevních transfúzí nebo substituční léčby imunoglobulinovými preparáty.
Links
7E08062, research and development projectName: Pathophysiology and Natural Course of Primary Antibody Deficiency (PAD) Syndromes
Investor: Ministry of Education, Youth and Sports of the CR, Pathophysiology and Natural Course of Primary Antibody Deficiency (PAD) Syndromes
PrintDisplayed: 27/7/2024 18:31